As the cytosolic guardian for many microbial and sterile inflammatory insults, NLRP3 is best appreciated for its innate immunological role mediating inflammasome activation. Now NLRP3 debuts as a transcription factor key for T H 2 polarization.
Zhong-Jian Shen and James S. Malter are in the Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USa. e-mail: zhong.shen@utsouthwestern.edu or james.malter@utsouthwestern.edu T he transcription factor XBP1 is essential for the development of cells with a secretory phenotype and presumably serves this function by modulating the unfolded protein response (UPR) during ongoing endoplasmic reticulum (ER) stress 1 . A function for XBP1 in the differen tiation of hematopoietic stem cells has not been described. In this issue of Nature Immunology, Bettigole et al. demonstrate that deletion of Xbp1 in the hematopoietic lineage selectively and potently prevents the maturation of eosino phil progenitors (EoPs) without affecting other lineages in the bone marrow 2 (Fig. 1) .
The genetargeting strategy used by Bettigole et al. has unexpectedly created a novel strain of mice with a highly specific defect in eosino philopoiesis and a complete lack of mature, circulating peripheral blood eosinophils 2 . The authors use a Vav1Cre mouse (express ing Cre recombinase from the hematopoietic compartment-specific Vav1 promoter) for specific deletion of Xbp1 in multilineage hematopoietic progenitor cells that give rise to myeloid cells-granulocytes (eosino phils, neutrophils, basophils, monocytes and mast cells) and lymphoid cells-lymphocytes (B cells, T cells and natural killer cells) (Fig. 1) . They show that XBP1 is highly and selectively activated during the commitment of gran ulocytemonocyte progenitors (GMPs) to development into eosinophils and that, in its absence, EoPs exhibit defective protein folding and attenuated granule formation, which leads to differentiation arrest and cell death.
Since its discovery in 1879, the eosinophil has remained an intriguing but generally poorly understood granulocyte. Because of its appar ent involvement in innate and adoptive immu nity and its presence in a variety of increasingly common human diseases, including parasitic infection, allergy, hyper eosinophilic syndrome and esophagitis, the eosinophil has engen dered considerable recent research atten tion. Eosinophils, along with neutrophils and basophils, constitute the three principal types of XBP1, a determinant of the eosinophil lineage
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Targeted deletion of the transcription factor XBP1 in hematopoietic stem cells selectively prevents eosinophil maturation in the bone marrow without affecting other lineages of the immune system. blood granulocytes. They are distinguishable by their appearance after treatment with Wright's stain. At the earliest stages of eosinophil differ entiation, cytoplasmic granule proteins appear. These are released at sites of inflammation and have a crucial role in the killing of microor ganisms and parasites as well as in response to allergens. Each granulocyte type synthesizes distinct granule proteins (cationic proteins, enzymes, cytokines and chemokines) and differentiates through the coordinated activity of multiple, overlapping transcription factors (for example, GATA1, GATA2, PU.1 and C/EBPα) in response to signaling from distinct cytokines (including interleukin 3 (IL3), IL4, IL5, GMCSF, MCSF and GCSF). So far, no single master factor has been identified that controls the commitment of GMPs to develop into EoPs. XBP1 is the first transcription fac tor identified that uniquely distinguishes the development of eosinophils from that of other granulocytes and has an indispensable role in the terminal differentiation of the eosinophil lineage ( Fig. 1) .
In highly secretory cells (such as granulo cytes, plasma cells, and Paneth and pancreatic acinar cells) with extensive ER networks, the folding of nascent proteins is extremely error prone. Thus, these cells must cope with the continuous burden of misfolded or unfolded proteins and substantial ER stress. This dilemma is resolved by the timely activation of adaptive UPR pathways to reduce the influx of proteins into the ER (the ER stress response) and activate degradation pathways to dispose of cytotoxic proteins. The endoribonuclease IRE1 and XBP1 represent a component of three mammalian UPR pathways also found in the eosinophil lineage 2 . When ER stress occurs, IRE1 translocates into the nucleus, binds ER stressresponse elements and induces the transcription of Xbp1 and genes encoding chaperones that are involved in ERassociated protein degradation 1 . During maturation, pro genitors of eosinophils are abruptly faced with the physiological demands of granuleprotein production, which forces these cells to rapidly adapt to escalating ER stress with enhanced proteinfolding capacity. Not surprisingly, Xbp1null EoPs are extremely sensitive to ER stress and attempt to compensate for the absence of XBP1 by upregulating expression of the kinase PERK and transcription factor ATF4 (ref. 2) , an alternative UPR pathway. While cells lacking XBP1 are able to produce eosinophilspecific granule proteins and some immature granule structures 2 , the aggregate UPR response is inadequate for the restoration formation and transcriptional activity have, until now, been considered mutually exclusive. In this issue, Bruchard et al. reveal a surprising and unexpected role for NLRP3 in the T H 2 sub set of CD4 + helper T cells, which have immune system-polarizing roles that form the basis of asthma and potentially tumor immunity 1 . Instead of acting to trigger an inflammasome in these cells, NLRP3 plays the curious role of a nuclear DNAbinding transcription factor and acts together in complex with transcription fac tor IRF4 to promote IL4 production (Fig. 1) . In this fashion, without the aid of ASC or a vast array of potential insults, from inor ganic mineral and organic salt crystals to bacterial endotoxin and viral nucleic acids. By assembling a multiprotein inflammasome complex containing the adaptor ASC and the aspartic protease caspase1, NLRP3 activates caspase1 to elaborate the cytokines inter leukin 1β (IL1β) and IL18. NLRP3 also triggers caspase1dependent and caspase1 independent celldeath pathways. While two other members of the large NLR family of recep tors, CIITA (NLRA) and NLRC5, have roles in controlling transcription, inflammasome
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volume 16 number 8 August 2015 nature immunology mouse strain 2 . These animals will comple ment the currently available PHIL mice 10 and ∆dblGATA mice 11 , which, while eosinophil deficient, were created by lineagespecific expression of diphtheria toxin and ablation of Gata1, respectively. This new mouse strain will enable exploration of the cell type-specific relationship between XBP1 and the key devel opmental regulators GATA1 and GATA2 and how XBP1 regulates the production and assem bly of granule proteins, UPR and ER stress in precursors of eosinophils. It remains to be deter mined how well these mice will model eosino philic diseases such as allergic asthma, as loss of XBP1 affects the number of dendritic cells and XBP1 is expressed by multiple other mature cells of the immune system. Nonetheless, the Xbp1 null, PHIL and ∆dblGATA mice provide an impressive and expanding toolbox with which to delineate the essential roles of eosinophils in health and human diseases.
granule proteins, as well as their proper folding. A failure of either process results in defective granule formation and cell death. The mice lacking XBP1 show normal dif ferentiation and survival of GMPs, as well as normal commitment of GMPs to develop into EoPs 2 . These findings are somewhat unex pected, as Mbp1 -/-Epx -/-mice showed a failure of GMP proliferation and commitment to differentiation into EoPs 7 . All known posi tive regulators (GATA1, GATA2, C/EBPs, PU.1 and Id2) and negative regulators (FOG1 and Id1) of eosinophil develop ment are expressed normally in Xbp1null GMPs 2 . These results indicate that XBP1 does not regulate the expression of MBP1 and EPX by GMPs, although these factors are essential for the GMPtoEoP transi tion. One possibility is that the activation of alternative UPR pathways, such as signaling via PERK and ATF6, in Mbp1 -/-Epx -/-cells contributes to the resolution of misfolded proteininduced ER stress and enables the commitment of GMPs to development into EoPs. Regardless of the mechanism involved, the data by Bettigole et al. show that eosino phil granulogenesis is a critical developmen tal checkpoint and that if it is defective, it disrupts lineagespecific regulatory events required for continued selfrenewal and cell survival 2 . It remains to be determined if cell death is caused by impaired granulogen esis itself or by cytoplasmic release of toxic proteins 8 , ER collapse 9 or other processes.
In summary, Bettigole et al. provide to the research community a novel eosinophildeficient of ER homeostasis, which leads to the down regulation of GATA1 activity, reduced tran scription of genes encoding eosinophil granule and eventual cell death.
The IRE1XBP1 pathway is the most highly conserved ERstress sensor in eukaryotes, and mice that lack IRE1 or XBP1 die in utero at an early developmental stage 3, 4 . Most cells of the immune system, however, do not require XBP1 to survive developmental ER stress. Plasma cells that lack XBP1 are found in normal numbers but their maturation and immunoglobulin produc tion are reduced 5 . In addition, total bone mar row cellularity and number of splenic cells of the immune system are unaffected by XBP1 defi ciency, although a minor decrease in the number of splenic dendritic cells is present 2 . Thus, with the exception of eosinophils, XBP1 deficiency is generally well tolerated across the rest of the immune system. Presumably this eosinophil sensitivity reflects the unique composition of granule proteins (for example, eosinophil per oxidase (EPX), eosinophilderived neurotoxin and eosinophil cationic protein, among others) that are highly basic (isoelectric point, ~9-11) and cytotoxic and exhibit membranedestabiliz ing properties 6 , especially if misfolded. However, the absence of prominent granule proteins is also deleterious for successful eosinophil differen tiation, as mice with dual deletion of the most abundant eosinophil lineagespecific cationic granule proteins, MBP1 and EPX (Mbp1 -/-Epx -/-mice) 7 , are also deficient in eosinophils. These data suggest that successful eosinophil differentiation requires the temporally and quantitatively appropriate production of various
